L26/O-223 Defining the optimal number of vitrified donor oocytes to maximise cumulative live birth rates in oocyte donation programmes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. De Lima und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What is the optimal number of vitrified donor oocytes to be warmed to maximise cumulative pregnancy and live birth rates per completed cycle? Summary answer Warming approximately eight vitrified donor oocytes maximises cumulative pregnancy and live birth rates, with diminishing returns beyond this threshold. What is known already Oocyte donation programmes increasingly rely on vitrified oocytes, yet the optimal number of oocytes required per recipient remains unclear. Warming excessive numbers of donor oocytes may lead to unnecessary embryo surplus and inefficient resource use, potentially limiting oocyte availability for other recipients. Conversely, insufficient oocyte numbers may compromise cumulative live birth rates. Most existing evidence focuses on per-transfer outcomes rather than cumulative, programme-level efficiency. Defining an evidence-based oocyte number is therefore essential to optimise clinical outcomes while minimising oocyte wastage and improving equitable access to donor oocytes. Study design, size, duration This retrospective cohort study evaluated an oocyte donation programme using vitrified donor oocytes conducted between 2021 and 2024 in a private assisted reproduction center. A total of 438 recipient cycles with complete follow-up were included. Cycles were stratified according to the number of oocytes warmed (4–6, 7–9, ≥10) and surviving after warming (3–6, 7–9, ≥10). Cumulative pregnancy (CP) and cumulative live birth (CLB) per cycle were the primary outcomes. Participants/materials, setting, methods Univariate analyses compared outcomes across warmed and surviving oocyte groups. Multivariable logistic regressions assessed independent predictors of cumulative pregnancy and live birth, adjusting for sperm concentration and donor, recipient, and paternal ages. Non-linear associations were explored using restricted cubic splines to estimate the number of warmed oocytes associated with ≥95% of the maximum predicted probability of cumulative outcomes. A secondary binary analysis (≥8 vs < 8 warmed oocytes) was performed to derive a clinically applicable threshold. Main results and the role of chance CP and CLB were 75.6% and 68.0%, respectively. Cycles with 7–9 and ≥10 warmed oocytes achieved higher CP (80.2% and 86.2%, respectively) and CLB rates (74.9% and 72.4%, respectively) compared with those with 4–6 (68.6% and 60.4%, for CP and CLB, respectively; p = 0.018 and p = 0.016). In multivariable analyses, the number of warmed oocytes was independently associated with CP (OR 1.47; 95% CI 1.056–2.063; p = 0.0226) and CLB (OR 1.31; 95% CI 1.111–1.766; p = 0.0456). In restricted cubic spline–adjusted analyses (adjusted for donor and paternal ages), the probability of CLB increased monotonically with the number of warmed oocytes. The model indicated an increase in cumulative live rate from 58.6% with five oocytes to 75.1% with eight oocytes, with progressively smaller absolute gains beyond this range. Using a pragmatic, efficiency-based clinical criterion, defined as achieving a high CLB probability with marginal gains below 1 percentage point per additional oocyte, eight warmed oocytes were identified as the optimal number. At this point, the model estimated a CLB probability of 75.1% (95% CI 64.7–78.2). Consistently, when modelled dichotomously, warming ≥8 oocytes was associated with a higher likelihood of CLB compared with <8 oocytes (OR 1.87; 95% CI 1.11–3.16; p = 0.019). Limitations, reasons for caution The retrospective single-centre design limits generalisability and causal inference. Residual confounding cannot be excluded, and findings may vary across programmes with different laboratory performance. Wider implications of the findings These findings provide objective guidance on the number of vitrified donor oocytes to be warmed per recipient. Defining an evidence-based threshold supports individualised counselling, improves programme efficiency, reduces unnecessary oocyte utilisation, and promotes equitable access to donor oocytes while maintaining high cumulative live birth rates. Trial registration number No
Zitieren
APA
Lima, C. D., Valle, M., Deveza, D., Mendes, A., Armond, B., Homem, A., & Oliveira, A. (2026). L26/O-223 Defining the optimal number of vitrified donor oocytes to maximise cumulative live birth rates in oocyte donation programmes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.221
Vancouver
Lima CD, Valle M, Deveza D, Mendes A, Armond B, Homem A, et al. L26/O-223 Defining the optimal number of vitrified donor oocytes to maximise cumulative live birth rates in oocyte donation programmes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.221
BibTeX
@article{Lima2026,
author = {Lima, C. De and Valle, M. and Deveza, D. and Mendes, A. and Armond, B. and Homem, A. and Oliveira, A.},
title = {L26/O-223 Defining the optimal number of vitrified donor oocytes to maximise cumulative live birth rates in oocyte donation programmes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.221}
}
EUVIMED